RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)
EUR 14.8
(-2.63%)
EUR 14.8
(-2.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 40.39 Million EUR | -153.95% |
| 2022 | 36.11 Million EUR | 18.33% |
| 2021 | 30.51 Million EUR | 188.0% |
| 2020 | 10.59 Million EUR | -81.34% |
| 2019 | 56.8 Million EUR | -12.53% |
| 2018 | 64.94 Million EUR | 67.82% |
| 2017 | 38.69 Million EUR | -60.1% |
| 2016 | 96.99 Million EUR | 4.14% |
| 2015 | 93.13 Million EUR | -93.0% |
| 2014 | 1.33 Billion EUR | 754.49% |
| 2013 | 155.74 Million EUR | 3.62% |
| 2012 | 150.3 Million EUR | -29.5% |
| 2011 | 213.18 Million EUR | 7.75% |
| 2010 | 197.85 Million EUR | 8.71% |
| 2009 | 181.99 Million EUR | 5.77% |
| 2008 | 172.07 Million EUR | 9.26% |
| 2007 | 157.49 Million EUR | 7.76% |
| 2006 | 146.14 Million EUR | 4.33% |
| 2005 | 140.07 Million EUR | 13.16% |
| 2004 | 123.78 Million EUR | -1.46% |
| 2003 | 125.61 Million EUR | 6.96% |
| 2002 | 117.44 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 8.61 Million EUR | -13.53% |
| 2024 Q1 | 9.95 Million EUR | -36.31% |
| 2023 Q4 | 15.63 Million EUR | 31.16% |
| 2023 Q1 | 6.21 Million EUR | -47.47% |
| 2023 Q3 | 11.91 Million EUR | 94.34% |
| 2023 FY | -19.48 Million EUR | -153.95% |
| 2023 Q2 | 6.13 Million EUR | -1.38% |
| 2022 Q1 | 2.53 Million EUR | -79.54% |
| 2022 Q2 | 15.59 Million EUR | 515.39% |
| 2022 FY | 36.11 Million EUR | 18.33% |
| 2022 Q3 | 6.14 Million EUR | -60.59% |
| 2022 Q4 | 11.83 Million EUR | 92.66% |
| 2021 Q2 | 9.45 Million EUR | 402.45% |
| 2021 Q3 | 6.8 Million EUR | -28.02% |
| 2021 Q4 | 12.38 Million EUR | 82.04% |
| 2021 Q1 | 1.88 Million EUR | 42.28% |
| 2021 FY | 30.51 Million EUR | 188.0% |
| 2020 FY | 10.59 Million EUR | -81.34% |
| 2020 Q3 | 7.9 Million EUR | 79.05% |
| 2020 Q4 | 1.32 Million EUR | -83.28% |
| 2020 Q2 | 4.41 Million EUR | 44.99% |
| 2020 Q1 | 3.04 Million EUR | -72.43% |
| 2019 Q1 | 11.14 Million EUR | 43.37% |
| 2019 FY | 56.8 Million EUR | -12.53% |
| 2019 Q2 | 15.49 Million EUR | 39.03% |
| 2019 Q3 | 19.12 Million EUR | 23.42% |
| 2019 Q4 | 11.04 Million EUR | -42.24% |
| 2018 Q2 | 8.36 Million EUR | -33.09% |
| 2018 Q3 | 36.31 Million EUR | 334.23% |
| 2018 Q4 | 7.77 Million EUR | -78.59% |
| 2018 Q1 | 12.49 Million EUR | 140.95% |
| 2018 FY | 64.94 Million EUR | 67.82% |
| 2017 Q3 | 12.6 Million EUR | 26.23% |
| 2017 FY | 38.69 Million EUR | -60.1% |
| 2017 Q4 | 5.18 Million EUR | -58.85% |
| 2017 Q2 | 9.98 Million EUR | -8.54% |
| 2017 Q1 | 10.91 Million EUR | 10.3% |
| 2016 Q1 | 53.18 Million EUR | 154.75% |
| 2016 Q2 | 20.73 Million EUR | -61.02% |
| 2016 Q3 | 13.17 Million EUR | -36.47% |
| 2016 Q4 | 9.89 Million EUR | -24.85% |
| 2016 FY | 96.99 Million EUR | 4.14% |
| 2015 Q2 | 19.17 Million EUR | -44.63% |
| 2015 Q1 | 34.63 Million EUR | 924.01% |
| 2015 FY | 93.13 Million EUR | -93.0% |
| 2015 Q4 | 20.87 Million EUR | 13.17% |
| 2015 Q3 | 18.45 Million EUR | -3.79% |
| 2014 Q4 | 3.38 Million EUR | -83.67% |
| 2014 Q2 | -167.01 Million EUR | -111.33% |
| 2014 FY | 1.33 Billion EUR | 754.49% |
| 2014 Q3 | 20.7 Million EUR | 112.4% |
| 2014 Q1 | 1.47 Billion EUR | 3797.31% |
| 2013 Q3 | 36.53 Million EUR | -12.04% |
| 2013 Q4 | 37.81 Million EUR | 3.51% |
| 2013 FY | 155.74 Million EUR | 3.62% |
| 2013 Q2 | 41.53 Million EUR | 4.2% |
| 2013 Q1 | 39.86 Million EUR | 2.59% |
| 2012 Q3 | 34.6 Million EUR | 22.31% |
| 2012 Q2 | 28.29 Million EUR | -41.72% |
| 2012 Q1 | 48.54 Million EUR | -19.36% |
| 2012 FY | 150.3 Million EUR | -29.5% |
| 2012 Q4 | 38.85 Million EUR | 12.28% |
| 2011 Q2 | 51.74 Million EUR | 2.27% |
| 2011 Q1 | 50.59 Million EUR | 1.31% |
| 2011 Q3 | 50.64 Million EUR | -2.14% |
| 2011 Q4 | 60.2 Million EUR | 18.88% |
| 2011 FY | 213.18 Million EUR | 7.75% |
| 2010 Q1 | 46.75 Million EUR | -0.95% |
| 2010 FY | 197.85 Million EUR | 8.71% |
| 2010 Q4 | 49.94 Million EUR | 0.72% |
| 2010 Q3 | 49.58 Million EUR | -3.85% |
| 2010 Q2 | 51.57 Million EUR | 10.31% |
| 2009 FY | 181.99 Million EUR | 5.77% |
| 2009 Q4 | 47.19 Million EUR | 8.17% |
| 2009 Q3 | 43.63 Million EUR | -9.88% |
| 2009 Q2 | 48.41 Million EUR | 13.26% |
| 2009 Q1 | 42.75 Million EUR | 0.0% |
| 2008 FY | 172.07 Million EUR | 9.26% |
| 2007 FY | 157.49 Million EUR | 7.76% |
| 2006 FY | 146.14 Million EUR | 4.33% |
| 2005 FY | 140.07 Million EUR | 13.16% |
| 2004 FY | 123.78 Million EUR | -1.46% |
| 2003 FY | 125.61 Million EUR | 6.96% |
| 2002 FY | 117.44 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 1.36 Billion EUR | 97.05% |
| Fresenius SE & Co. KGaA | 1.14 Billion EUR | 96.466% |
| LIMES Schlosskliniken AG | 5.02 Million EUR | -703.818% |
| M1 Kliniken AG | 15.69 Million EUR | -157.32% |
| Maternus-Kliniken Aktiengesellschaft | -9.26 Million EUR | 536.274% |
| MEDICLIN Aktiengesellschaft | 12.72 Million EUR | -217.558% |
| VITA 34 AG | -3.12 Million EUR | 1394.84% |